Gerald W. McLaughlin's Net Worth
$1.49 Million
Who is Gerald W. McLaughlin?
Gerald W. McLaughlin has an estimated net worth of $1.49 Million. This is based on reported shares across multiple companies, which include NUPATHE INC., Neos Therapeutics, Inc., AYTU BIOPHARMA, INC, Nemus Bioscience, Inc., and Allarity Therapeutics, Inc..
SEC CIK
Gerald W. McLaughlin's CIK is 0001495412
Past Insider Trading and Trends
2015 was Gerald W. McLaughlin's most active year for acquiring shares with 4 total transactions. Gerald W. McLaughlin's most active month to acquire stocks was the month of February. 2021 was Gerald W. McLaughlin's most active year for disposing of shares, totalling 7 transactions. Gerald W. McLaughlin's most active month to dispose stocks was the month of February. 2018 saw Gerald W. McLaughlin paying a total of $51,239.01 for 624,500 shares, this is the most they've acquired in one year. In 2014 Gerald W. McLaughlin cashed out on 242,400 shares for a total of $1,494,581.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NUPATHE INC. No price found
SVP, Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -156.65K |
$6.80 | -$1,065,226.80 |
0
|
Feb 21
| |||
Form 4
| +394.93% | 125K |
—
|
—
| 156.65K |
Jan 17
| |||
Form 4
|
∞
| 31.65K |
—
|
—
| 31.65K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Neos Therapeutics, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -270.17K |
—
|
—
|
0
|
Mar 19
| |||
Form 4
| -14.10% | -44.33K |
$0.84 | -$37,413.68 | 270.17K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
| +1,183.67% | 290K |
—
|
—
| 314.5K |
Mar 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +230.95% | 17.1K |
$2.11 | $36,119.12 | 24.5K |
Dec 6
| |||
Form 4
|
∞
| 7.4K |
$2.04 | $15,119.89 | 7.4K |
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AYTU BIOPHARMA, INC (AYTU) Snapshot price: $2.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +26.10% | 6.5K |
—
|
—
| 31.4K |
Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Nemus Bioscience, Inc. (SKYE) Snapshot price: $5.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +96.00% | 30K |
—
|
—
| 61.25K |
Oct 20
| |||
Form 4
|
∞
| 31.25K |
—
|
—
| 31.25K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Allarity Therapeutics, Inc. (ALLR) Snapshot price: $0.165
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |